Assessment of early response to concurrent chemoradiotherapy in cervical cancer: Value of diffusion-weighted and dynamic contrast-enhanced MR imaging

Magnetic Resonance Imaging

Volumn 32, Issue 8, 2014, Pages 993-1000

  Park, Jung Jae ^a   Kim, Chan Kyo ^a   Park, Sung Yoon ^a,d   Simonetti, Arjan W ^b   Kim, EunJu ^b,c   Park, Byung Kwan ^a   Huh, Seung Jae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b PHILIPS HEALTHCARE   (United States)

^c Hanyang University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Biomarker; Cervical cancer; Concurrent chemoradiotherapy; Diffusion weighted MRI; Dynamic contrast enhanced MRI

Indexed keywords

CISPLATIN; FLUOROURACIL; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; FEMALE; GAMMA RADIATION; GLUTEUS MAXIMUS MUSCLE; HUMAN; IMAGE ANALYSIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION RESPONSE; REPRODUCIBILITY; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX CANCER; BIOPSY; BRACHYTHERAPY; CHEMISTRY; FOLLOW UP; IMAGE PROCESSING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; SKELETAL MUSCLE; TIME; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; BIOPSY; BRACHYTHERAPY; CHEMORADIOTHERAPY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUSCLE, SKELETAL; REPRODUCIBILITY OF RESULTS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84906064828     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2014.05.009     Document Type: Article

References (33)

1. Monk B.J., Tewari K.S., Koh W.J. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol 2007, 25:2952-2965.
2. Thomas G.M. Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N Engl J Med 1999, 340:1198-1200.
3. Kirwan J.M., Symonds P., Green J.A., Tierney J., Collingwood M., Williams C.J. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003, 68:217-226.
4. Eisenhauer E.A., Therasse P., Bogaerts J., Schwartz L.H., Sargent D., Ford R., et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45:228-247.
5. Pickles M.D., Gibbs P., Lowry M., Turnbull L.W. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006, 24:843-847.
6. Britten R.A., Evans A.J., Allalunis-Turner M.J., Franko A.J., Pearcey R.G. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Radiother Oncol 1996, 39:145-153.
7. Koh D.M., Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007, 188:1622-1635.
8. Hamstra D.A., Rehemtulla A., Ross B.D. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 2007, 25:4104-4109.
9. Knopp M.V., Giesel F.L., Marcos H., von Tengg-Kobligk H., Choyke P. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging 2001, 12:301-308.
10. Tomura N., Omachi K., Sakuma I., Takahashi S., Izumi J., Watanabe O., et al. Dynamic contrast-enhanced magnetic resonance imaging in radiotherapeutic efficacy in the head and neck tumors. Am J Otolaryngol 2005, 26:163-167.
11. Pickles M.D., Lowry M., Manton D.J., Gibbs P., Turnbull L.W. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005, 91:1-10.
12. Harry V.N., Semple S.I., Gilbert F.J., Parkin D.E. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 2008, 111:213-220.
13. Kim H.S., Kim C.K., Park B.K., Huh S.J., Kim B. Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging. J Magn Reson Imaging 2013, 37:187-193.
14. Kuang F., Yan Z., Wang J., Rao Z. The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer. Magn Reson Imaging 2014, 32:342-349.
15. Makino H., Kato H., Furui T., Morishige K.I., Kanematsu M. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer. J Obstet Gynaecol Res 2014, 40:1098-1104.
16. Semple S.I., Harry V.N., Parkin D.E., Gilbert F.J. A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2009, 75:611-617.
17. Kim J.H., Kim C.K., Park B.K., Park S.Y., Huh S.J., Kim B. Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy. Eur Radiol 2012, 22:2533-2539.
18. Andersen E.K., Hole K.H., Lund K.V., Sundfor K., Kristensen G.B., Lyng H., et al. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome. Radiother Oncol 2013, 107:117-122.
19. Liu Y., Bai R., Sun H., Liu H., Zhao X., Li Y. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. Clin Radiol 2009, 64:1067-1074.
20. Wang H.Z., Riederer S.J., Lee J.N. Optimizing the precision in T1 relaxation estimation using limited flip angles. Magn Reson Med 1987, 5:399-416.
21. Murase K. Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med 2004, 51:858-862.
22. Naganawa S., Sato C., Kumada H., Ishigaki T., Miura S., Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 2005, 15:71-78.
23. McVeigh P.Z., Syed A.M., Milosevic M., Fyles A., Haider M.A. Diffusion-weighted MRI in cervical cancer. Eur Radiol 2008, 18:1058-1064.
24. Nam H., Park W., Huh S.J., Bae D.S., Kim B.G., Lee J.H., et al. The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol Oncol 2007, 107:320-325.
25. Zahra M.A., Hollingsworth K.G., Sala E., Lomas D.J., Tan L.T. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 2007, 8:63-74.
26. Zahra M.A., Tan L.T., Priest A.N., Graves M.J., Arends M., Crawford R.A., et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 2009, 74:766-773.
27. Loncaster J.A., Carrington B.M., Sykes J.R., Jones A.P., Todd S.M., Cooper R., et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002, 54:759-767.
28. Lim K., Chan P., Dinniwell R., Fyles A., Haider M., Cho Y.B., et al. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia. Int J Radiat Oncol Biol Phys 2008, 70:126-133.
29. Tofts P.S., Berkowitz B., Schnall M.D. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995, 33:564-568.
30. Hayes C., Padhani A.R., Leach M.O. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002, 15:154-163.
31. Heye T., Davenport M.S., Horvath J.J., Feuerlein S., Breault S.R., Bashir M.R., et al. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions. Radiology 2013, 266:801-811.
32. Galbraith S.M., Lodge M.A., Taylor N.J., Rustin G.J., Bentzen S., Stirling J.J., et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 2002, 15:132-142.
33. Jackson A., Jayson G.C., Li K.L., Zhu X.P., Checkley D.R., Tessier J.J., et al. Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. Br J Radiol 2003, 76:153-162.